L-acetylcarnitine in stabilized cerebrovascular lesions. A neuropsychological study: preliminary data

C. Crisci, L. Trojano, B. Lanzillo, R. Massini, N. Pappone

Research output: Contribution to journalArticle

Abstract

In this study, an investigation into the mode of action of L-acetylcarnitine (L-Ac), a naturally occurring substance with properties capable of improving some neuropsychological functions, is described. Seventeen patients with clinical signs and symptoms of cerebrovascular damage giving rise to neurovascular deficits were studied, using a comprehensive series of neuropsychological and clinical tests. Nine of the 17 were given L-Ac orally, 500 mg b.d. for 2-3 months. They were all receiving other drug therapy as necessary and undergoing neurological rehabilitation and antiparalysis therapy. The findings showed an improved performance in attention tests in the nine patients treated with L-Ac as compared to the controls. This is considered possibly due to an overall activation of cognitive functions.

Original languageEnglish
Pages (from-to)77-82
Number of pages6
JournalClinical Trials Journal
Volume25
Issue numberSUPPL. 1
Publication statusPublished - 1988

Fingerprint

Acetylcarnitine
Neuropsychological Tests
Cognition
Signs and Symptoms
Drug Therapy
Therapeutics

ASJC Scopus subject areas

  • Pharmacology (medical)

Cite this

L-acetylcarnitine in stabilized cerebrovascular lesions. A neuropsychological study : preliminary data. / Crisci, C.; Trojano, L.; Lanzillo, B.; Massini, R.; Pappone, N.

In: Clinical Trials Journal, Vol. 25, No. SUPPL. 1, 1988, p. 77-82.

Research output: Contribution to journalArticle

@article{51a1c93b60a34e43a39b0063f3638d0c,
title = "L-acetylcarnitine in stabilized cerebrovascular lesions. A neuropsychological study: preliminary data",
abstract = "In this study, an investigation into the mode of action of L-acetylcarnitine (L-Ac), a naturally occurring substance with properties capable of improving some neuropsychological functions, is described. Seventeen patients with clinical signs and symptoms of cerebrovascular damage giving rise to neurovascular deficits were studied, using a comprehensive series of neuropsychological and clinical tests. Nine of the 17 were given L-Ac orally, 500 mg b.d. for 2-3 months. They were all receiving other drug therapy as necessary and undergoing neurological rehabilitation and antiparalysis therapy. The findings showed an improved performance in attention tests in the nine patients treated with L-Ac as compared to the controls. This is considered possibly due to an overall activation of cognitive functions.",
author = "C. Crisci and L. Trojano and B. Lanzillo and R. Massini and N. Pappone",
year = "1988",
language = "English",
volume = "25",
pages = "77--82",
journal = "Clinical Trials Journal",
issn = "0009-9325",
publisher = "Elsevier BV",
number = "SUPPL. 1",

}

TY - JOUR

T1 - L-acetylcarnitine in stabilized cerebrovascular lesions. A neuropsychological study

T2 - preliminary data

AU - Crisci, C.

AU - Trojano, L.

AU - Lanzillo, B.

AU - Massini, R.

AU - Pappone, N.

PY - 1988

Y1 - 1988

N2 - In this study, an investigation into the mode of action of L-acetylcarnitine (L-Ac), a naturally occurring substance with properties capable of improving some neuropsychological functions, is described. Seventeen patients with clinical signs and symptoms of cerebrovascular damage giving rise to neurovascular deficits were studied, using a comprehensive series of neuropsychological and clinical tests. Nine of the 17 were given L-Ac orally, 500 mg b.d. for 2-3 months. They were all receiving other drug therapy as necessary and undergoing neurological rehabilitation and antiparalysis therapy. The findings showed an improved performance in attention tests in the nine patients treated with L-Ac as compared to the controls. This is considered possibly due to an overall activation of cognitive functions.

AB - In this study, an investigation into the mode of action of L-acetylcarnitine (L-Ac), a naturally occurring substance with properties capable of improving some neuropsychological functions, is described. Seventeen patients with clinical signs and symptoms of cerebrovascular damage giving rise to neurovascular deficits were studied, using a comprehensive series of neuropsychological and clinical tests. Nine of the 17 were given L-Ac orally, 500 mg b.d. for 2-3 months. They were all receiving other drug therapy as necessary and undergoing neurological rehabilitation and antiparalysis therapy. The findings showed an improved performance in attention tests in the nine patients treated with L-Ac as compared to the controls. This is considered possibly due to an overall activation of cognitive functions.

UR - http://www.scopus.com/inward/record.url?scp=0024234679&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024234679&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0024234679

VL - 25

SP - 77

EP - 82

JO - Clinical Trials Journal

JF - Clinical Trials Journal

SN - 0009-9325

IS - SUPPL. 1

ER -